With CCI and TexRAD, Feedback has firmly repositioned itself as specialists in quantitative tools for medical imaging.
Feedback develops software and systems that provide innovative techniques and improved workflows for practitioners involved in medical research and treating patients. The company builds products that puts new and more effective tools into the hands of clinical decision makers, improving patient care and reducing costs. Feedback also provides its system as a platform to accelerate other imaging tools to market.
- Alan Green CEO of Brand Communications discusses Feedback #FDBK and gives the bull case for Metro Bank #MTRO
- Alan Green discusses Bidstack #BIDS, Team 17 #TM17, Feedback #FDBK and IMC Exploration #IMC on the Vox Markets podcast
- Alan Green talks ECR Minerals #ECR, Smart Metering #SMS, Sativa Group #SATI, Feedback #FDBK & Petrel Resources #PET on Vox Markets podcast
- Alan Green covers Thomas Cook #TCG, Volga Gas #VGAS, Feedback #FDBK, Open Orphan #ORPH and European Metal Holdings #EMH on Vox Markets podcast
- Brand CEO Alan Green talks Feedback #FDBK, European Metals #EMH, Destiny Pharma #DEST & Bidstack #BIDS on the Vox Markets podcast
- Alan Green CEO of Brand Communications talks about: Prairie Mining #PDZ Gulf Keystone Petroleum #GKP Feedback #FDBK Vast Resources #VAST
- Alan Green CEO of Brand Communications talks about: Feedback #FDBK Catenae Innovations #CTEA Midwich #MIDW Andalas Energy & Power #ADL on the Vox Market Podcast
- Feedback Plc #FDBK – Trevor Brown shareholding
- Feedback #FDBK – Trevor Brown shareholding
- Feedback #FDBK – Appointment of Chief Financial Officer
- Brand CEO Alan Green talks Powerhouse Energy #PHE, Feedback #FDBK & Cambian Grp #CMBN on Vox Markets podcast
- Feedback #FDBK – Interim Report for the six months ended 30 November 2017
- Feedback #FDBK – Appointment of new CEO to drive growth strategy
- Feedback Plc #FDBK – Holdings in company
- Feedback #FDBK – Trevor Brown shareholding
- Brand CEO Alan Green talks Feedback #FDBK, Petrofac #PFC & Prairie Mining #PDZ on VOX Markets podcast
- Feedback Plc #FDBK – Holdings in Company
- Feedback Plc #FDBK – Holding in Company
- Feedback #FDBK – Result of AGM
- Feedback Plc #FDBK – Holdings in Company
- Feedback #FDBK – Presentation at RSNA 2017
- Round the Clock Trader today features Dr David Paul of VectorVest and Brand CEO Alan Green
- Feedback Plc (FDBK) – Trevor Brown shareholding
- Feedback plc #FDBK – First CE marked release of TexRAD® technology
- Small Cap Spotlight – Brand CEO Alan Green looks at Cadence Minerals #KDNC, Tertiary Minerals #TYM and Feedback #FDBK
- Feedback #FDBK – Final results, notice of AGM and TexRAD® Lung CE mark update.
- Impact of hepatocellular carcinoma heterogeneity on computed tomography as a prognostic indicator – Feedback Plc (FDBK)
- Feedback (FDBK) – TexRAD sponsor Mumbai American British Course in Neuroradiology
- A review of potential applications by TexRAD users from leading Universities across the USA – Feedback (FDBK)
- Paper from TexRAD collaboration with Neuroradiologists presented at BSNR conference at Queens’ College, Cambridge – Feedback (FDBK)
- Dr Balaji Ganeshan presents TexRAD at the prestigious Beijing Society of Radiology Conference – Feedback Plc (FDBK).
- Feedback (FDBK) – Trevor Brown shareholding
- TexRAD Texture Analysis of CT and MR images – ready for prime time at Beijing Radiation Academic Annual Conference – Feedback (FDBK)
- Feedback (FDBK) – Total Voting Rights
- Feedback (FDBK) subsidiary CCI signs exclusive agreement with Boya Digital Technology (Beijing) to distribute TexRAD in China
- Commercial Director appointed for CCI Ltd – Feedback (FDBK)
- Feedback (FDBK) – Trevor Brown shareholding
- Feedback (FDBK) – Issue of equity to TexRAD founder
- Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification – Feedback (FDBK).
- Prostate-specific membrane antigen PET-MRI validation of MR textural analysis for detection of transition zone prostate cancer? – Feedback (FDBK)
- Can TexRAD CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer? – Feedback (FDBK)
- Feedback (FDBK) – Timothy Irish appointed as Non-Exec as Trevor Brown resigns.
- Feedback (FDBK) subsidiary Cambridge Computed Imaging announces exclusive distributor arrangement with Korea Computer Motion ISG
- Feedback (FDBK) – Total voting rights
- Feedback Plc (FDBK) – Further re. Resignation of Director Tom Charlton
- Proactive Investment Overview – Feedback PLC’s eye on the prize: a CE mark for TexRAD
- Feedback (FDBK) – Progress with CE mark and trading update
- Feedback (FDBK) – University of Sussex shareholding
- Brand CEO Alan Green talks Andalas Energy (ADL), Feedback (FDBK) & Vipera (VIP) on Vox Markets podcast
- Feedback (FDBK) – Notice of Resignation of Director
- Zak Mir ProActive Investors Stocktube – Feedback PLC set to-re-test 5p over next 3-6 months
- Feedback (FDBK) – Issue of Equity
- Brand CEO Alan Green talks Cadence Minerals (KDNC), Feedback (FDBK) & Advanced Oncotherapy (AVO) on TipTV
- Feedback Plc (FDBK) – Brand CEO Alan Green discusses developments on the Vox Markets podcast
- Brand CEO Alan Green discusses Feedback (FDBK) and Victoria (VCP) on the Vox Markets podcast
- Feedback Chairman Dr Alastair Riddell discusses TexRAD Lung and other developments with Proactive’s Andrew Scott
- Correlation of CT Derived Texture Features with Mutational Status of Clear Cell Renal Carcinoma using TexRAD
- Feedback Plc (FDBK) – Letter of Intent signed and trading update
- Abdominal Radiology – Study using texture analysis (TexRAD) of the liver at MDCT for assessing hepatic fibrosis – Feedback plc
- TexRAD presentation at European Congress of Radiology (ECR) – Feedback (FDBK)
- Feedback (FDBK) – Appointment of Joint Broker
- Brand CEO Alan Green discusses Feedback (FDBK), Advanced Oncotherapy (AVO) & Defenx (DFX) on VOX Markets podcast
- 4 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
- 3 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
- Feedback Plc (FDBK) – Interim Report for six months ended 30 November 2016
- TexRAD paper wins registrars prize at ARGANZ 2017 meeting – Feedback Plc (FDBK)
- 2 – Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
- 1- Forthcoming TexRAD presentations at European Congress of Radiology (ECR) – Feedback (FDBK)
- Feedback (FDBK) – Two recently published papers on CT texture analysis
- Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) on the VOX Markets podcast
- Feedback (FDBK) – Re Media Articles
- Feedback (FDBK): Above 50 day line points as high as 5p – Master Investor
- Dr Balaji Ganeshan speaks at International Conference on Artificial Intelligence in Healthcare – Feedback plc (FDBK)
- Malcolm Stacey, ShareProphets – Tom no likey this medical pioneer. But I do…
- Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma – Feedback Plc (FDBK)
- Feedback Plc (FDBK) – Total Voting Rights
- Daily Mail – SMALL CAP IDEAS: Feedback’s new chairman reveals pioneering cancer imaging program is proving a hit
- TexRAD presenting 19 papers at RSNA 2016 – Feedback (FDBK)
- Feedback Plc (FDBK) – Director shareholding
- Feedback Plc (FDBK) – Issue of Equity & Director – PDMR shareholding
- Feedback Plc (FDBK) – Result of AGM
- Feedback chairman says cancer software has ‘real potential’ – Proactive Investors
- ‘Undoubtedly an exciting time for Texrad’ says Feedback Chairman – ProactiveInvestors Stocktube
- Brand CEO Alan Green on Feedback (FDBK), Barclays (BARC) & Conviviality Retail (CVR) on the VOX Markets podcast
- Feedback PLC (FDBK) – Attendance at RSNA 2016
- TexRAD imaging platform owned by Feedback Plc participates in India-UK TECH Summit
- Brand CEO Alan Green discusses Feedback (FDBK) developments & Tesco (TSCO) on VOX Markets podcast
- Feedback (FDBK) – Re Directorate
- Feedback PLC (FDBK) – Full year results to May 31 and prospects for the current year
- Brand CEO Alan Green talks Feedback (FDBK), Burberry (BRBY) & ASOS (ASC) on TipTV
- Feedback (FDBK) – Trading update
- Brand CEO Alan Green discusses Irish gold, IMC Exploration (IMCP) and Feedback (FDBK) on VOX Markets podcast
- Feedback (FDBK) – Collaboration with Future Processing
- Feedback (FDBK) – Appointment of Non-Executive Chairman
- Feedback (FDBK) sells stake in Stone Checker Software Ltd
- Feedback (FDBK) announces change of Nominated Advisor
- Feedback (FDBK) – Directors Talk interview with Dr Balaji Ganeshan
- Alan Green discusses Feedback (FDBK) & Smart Metering (SMS) on VOX Markets podcast
- Feedback (FDBK) – Interim Results for 6 months ended 30 Nov 2015
- Feedback PLC – Dr Balaji Ganeshan to present paper at prestigious Society of Cardiac MR (SCMR) in Jan 2016
- Feedback PLC – All resolutions passed at today’s AGM
- Feedback PLC director Dr Balaji Ganeshan discusses the latest TexRAD developments
- Feedback PLC – TexRAD signs MoU with Alliance Medical Group
- Malcolm Stacey of ShareProphets – My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacta & Advanced Oncotherapy
- Feedback PLC – New board appointments
- Feedback PLC – Announces final results & appoints Dr Balaji Ganeshan & Mike Hayball to the board
- Feedback PLC – ICENI Centre & ISLCRS study to investigate whether textural features of rectal cancer on Magnetic Resonance can predict long term survival
- Strategic alliance between Quibim and Feedback Plc to improve prostate biopsy
- Feedback Plc – Presentation of Study Results
- Feedback PLC – Chief Scientific Officer Dr Balaji Ganeshan discusses latest developments on the ADVFN podcast
- Feedback (FDBK) – Strategy update
- Malcolm Stacey of ShareProphets – Feedback PLC, Don’t You Hate the Small Profit-Takers?
- Malcolm Stacey of ShareProphets – Feedback and the Big Spanish Connection
- Feedback PLC – NHS England “Alert” on potential application of TexRAD for assessing lung cancer patients
- Feedback PLC forms JV with Quibim SL to develop Prostate Checker TexRAD application
- Alan Green discusses Feedback (FDBK) on TipTV
- Feedback PLC – Dr Balaji Ganeshan talks to DirectorsTalk about Stone Checker JV.
- Feedback PLC announces it has licensed TexRAD to Stone Checker
- More Feedback please! Alan Green discusses Feedback (FDBK) developments on the ADVFN podcast
- Feedback (FDBK) – First sale of TexRAD in China
- Feedback PLC (FDBK) – Total voting rights
- Feedback PLC (FDBK) – Study update
- Feedback (FDBK) – Exercise of Options
- Feedback PLC – Issue of equity
- Feedback PLC – Dr Balaji Ganeshan interviewed by Justin Waite on the ADVFN podcast
- Feedback PLC – Dr Balaji Ganeshan talking at UK Radiological Congress 2015
- Feedback (FDBK) – Total voting rights
- Feedback Plc (FDBK) – Archive posts
- ShareProphets – Feedback Shares Soften, but is that a Buying Opportunity?
- Feedback company TexRAD wins the inaugural Sussex Impact Award at the University of Sussex
- Feedback PLC announces the first server sale of TexRAD in Canada
- Feedback PLC – Statement re Share Price Movement
- Feedback (FDBK) raises £200,000 to fund TexRAD development
- Medical Imaging News – Stainless staining provides a new tool for clinicians and researchers
- Alan Green gives good Feedback on Feedback PLC with Justin Waite on the ADVFN podcast
- Medical Imaging News – Susceptibility Weighted Imaging in the Evaluation of Cerebrovascular Hemodynamics
- Feedback PLC – Collaboration with the University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Feedback PLC announces preliminary results from the Oxford Stone Group using TexRAD research software in the analysis of kidney stones
- Dr Balaji Ganeshan, Chief Scientist and New Business Officer at Feedback PLC is interviewed by Zak Mir on TipTV
- Feedback announces a new drug trial and provides a trading update
- Feedback announces a collaboration with Princess Alexandra Hospital, Brisbane, AU
- First sale of TexRAD in South Korea
We try to extract every ounce of benefit from medical images. We develop innovative techniques and improved workflows for practitioners involved in medical research and treating patients.